Company intelligence / Profile preview

Patheon

Waltham, Massachusetts, United Statespatheon.com ↗
Ownership
Public · TMO
Employees
~9000
Development stage
Commercial
01

Overview

Patheon has supported over 128 regulatory approvals (NDAs/BLAs) in the last five years and has extensive experience with both small molecules and biologics, including advanced therapies such as viral vectors and cell therapies. It does not have its own clinical results but enables those of its clients.

Modalities
Small moleculeBiologicViral vector therapyCell therapymRNA-based drugsPlasmid DNA therapiesOral solid dose formssoftgelssteriles
Industry
Contract Manufacturing Organization
02

Partnerships

Pharmaceutical and biotechnology companies (broad collaborations as service provider)

Beyond the preview

Go deeper on Patheon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Patheon.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call